Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance development and manufacturing across the entire drug lifecycle, as well as comprehensive analytical and IND enabling services. With over 40 years of experience and a team of 2,000 experts located in North America and Europe, Cambrex offers a range of specialized drug substance technologies to support biopharma companies with high-quality API for clinical development to commercial.